Respiratory Tract Infections: Clinical Trials

14686 trials for Respiratory Tract Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8885 completed, 2886 unknown, 882 terminated, 693 recruiting. 3656 Not applicable, 2500 Phase 2, 2021 Phase 3, 1325 Phase 1, 1070 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3656Completed 2230, Unknown 688, Recruiting 206, Terminated 159, Withdrawn 133, Not yet recruiting 115, Active not recruiting 86, Enrolling by invitation 26, Suspended 13
Phase 22500Completed 1443, Unknown 389, Terminated 306, Withdrawn 178, Recruiting 87, Active not recruiting 47, Not yet recruiting 38, Suspended 9, Enrolling by invitation 3
Phase 32021Completed 1235, Unknown 307, Terminated 211, Withdrawn 120, Recruiting 75, Active not recruiting 29, Not yet recruiting 28, Suspended 15, Enrolling by invitation 1
Phase 11325Completed 890, Unknown 174, Terminated 95, Withdrawn 76, Recruiting 46, Active not recruiting 23, Not yet recruiting 19, Enrolling by invitation 2
Phase 41070Completed 671, Unknown 185, Terminated 79, Recruiting 44, Withdrawn 31, Not yet recruiting 29, Active not recruiting 22, Suspended 6, Enrolling by invitation 3
Early Phase 1116Completed 50, Unknown 31, Recruiting 8, Not yet recruiting 7, Terminated 7, Withdrawn 7, Suspended 3, Active not recruiting 2, Enrolling by invitation 1

Follow this condition Literature Review of Respiratory Tract Infections trials Research Report on Respiratory Tract Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bubble CPAP Team-Based Care Strategy Feasibility Trial
bCPAP team-based care strategy - Pneumonia in Children
Not applicableNot yet recruitingYale University952028-04-012026-06-02
Perceptions of Undergraduate Students and Teaching Staff on Online Teaching
Questionnaire - Covid19
SuspendedMisr International University92092027-07-152026-10-08
Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
ID93 + GLA-SE vaccine, Placebo vaccine - Tuberculosis, Pulmonary
Phase 2Not yet recruitingAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections15002027-01-312026-08-24
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age
Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial
Phase 1Not yet recruitingGlaxoSmithKline602027-01-252026-07-16
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Metered cryospray (MCS) - COPD (Chronic Obstructive Pulmonary Disease), Chronic Bronchitis
Not applicableNot yet recruitingCSA Medical, Inc.102027-01-022026-10-05
Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress
Lift mobile mindfulness, Enlighten Recovery education program - Critical Illness, Heart Failure
Not applicableNot yet recruitingDuke University4502027-01-012026-07-08
Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO
Low anticoagulation dose of argatroban and enoxaparin during ECMO, Standard anticoagulation dose of argatroban and enoxaparin during ECMO - Pneumonia, Heart Failure
Phase 2Not yet recruitingUniversity Hospital Ostrava2002027-01-012026-04-02
Immune-Mitochondrial Correction in Military Recruits
Multivitamin/Mineral supplements, Sodium nucleinate combination - Respiratory Tract Infections (RTI), Meningitis
Not applicableNot yet recruitingMIPO Clinic2002027-01-012026-06-29
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms
IV infusion using an isolated, placental, mesenchymal stem cell derived EVs, Placebo IV administration - COVID-19
Phase 1 / Phase 2Not yet recruitingKimera Labs Inc.642027-01-012026-06-24
Taurine Supplementation in Adolescents With Post-COVID Condition
Taurine - Long COVID, Post COVID-19 Condition
Phase 1 / Phase 2Not yet recruitingUniversity of Alberta302026-12-302026-10-16
CD19-B Cell Depletion in PAIS-ME/CFS Patients
Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID)
Phase 2Not yet recruitingCharite University, Berlin, Germany382026-12-012026-07-24
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults
Bivalent RSV Vaccine (IN006), Placebo - Respiratory Syncytial Virus Infections
Phase 1Not yet recruitingShenzhen Shenxin Biotechnology Co., Ltd2002026-12-012026-04-13
Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi
Oteseconazole - Coccidioidomycosis, Blastomycosis
Phase 2Not yet recruitingUniversity of Minnesota302026-12-012026-09-04
How Healthy Adults Respond to the Nasal Flu Vaccine
FluMist (Live Attenuated Influenza Vaccine) - Mucosal Immune Response to Influenza Vaccination
Phase 4Not yet recruitingUniversity of Alabama at Birmingham202026-12-012026-10-13
A Human Influenza Transmission Study Using Naturally Infected Community Donors
Influenza Donor Visit, Influenza Recipient Inpatient Exposures Sessions - Influenza
Not applicableNot yet recruitingEmory University1502026-12-012026-09-11
Feasibility of Tracheobronchial Reconstruction Using Allogenic Aortic Patch in Children
Cryopreserved aorta - Trachea Diseases, Tracheal Stenosis
Not applicableEnrolling by invitationNational Taiwan University Hospital52026-12-012026-08-17
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
AVM0703, Placebo - ARDS, Covid19
Phase 1Not yet recruitingAVM Biotechnology Inc162026-12-012025-10-02
Ketogenic Approach to Restore Muscle in Older Patients With Community-Acquired Pneumonia - KARMA-P Trial
Ketogenic feeding, Standard feeding - Pneumonia
Not applicableNot yet recruitingUniversity of Alabama at Birmingham302026-11-302026-10-15
Evaluating Antibiotic Course Upon Adequate Treatment of Empyema
shortened antibiotic course, Standard medical treatment - Pleural Empyema
Not applicableNot yet recruitingUniversity of Arizona502026-11-162026-10-07

Showing 20 of 14686. Sign in to see all of them.

Narrower conditions

COVID-19 (7570)  ·  Influenza, Human (2156)  ·  Pneumonia (1382)  ·  Coronavirus Infections (838)  ·  Post-Acute COVID-19 Syndrome (596)  ·  Pneumonia, Ventilator-Associated (417)  ·  Severe Acute Respiratory Syndrome (357)  ·  Community-Acquired Pneumonia (322)  ·  Pulmonary Disease, Chronic Obstructive (316)  ·  Tuberculosis, Pulmonary (309)  ·  Virus Diseases (284)  ·  Respiratory Distress Syndrome (275)  ·  Whooping Cough (269)  ·  Bronchiolitis (260)

Broader conditions

Respiratory Tract Diseases (14589)  ·  Infections (14434)  ·  Lung Diseases (10819)  ·  RNA Virus Infections (10453)  ·  Virus Diseases (10348)  ·  Pneumonia (8696)  ·  Nidovirales Infections (8059)  ·  Coronaviridae Infections (8052)  ·  Pneumonia, Viral (7865)  ·  Coronavirus Infections (7242)  ·  Pathological Conditions, Signs and Symptoms (3266)  ·  Pathologic Processes (2568)  ·  Orthomyxoviridae Infections (2084)  ·  Disease Attributes (1855)

Interventions

Influenza Vaccines (431)  ·  Standard of Care (212)  ·  Sodium Chloride (183)  ·  Hydroxychloroquine (171)  ·  Blood Specimen Collection (168)  ·  Saline Solution (159)  ·  Surveys and Questionnaires (131)  ·  Azithromycin (125)  ·  BNT162 Vaccine (109)  ·  Oseltamivir (93)  ·  COVID-19 Vaccines (91)  ·  remdesivir (82)  ·  2019-nCoV Vaccine mRNA-1273 (75)  ·  Dexamethasone (73)  ·  Ivermectin (69)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (326)  ·  GlaxoSmithKline (318)  ·  Sanofi Pasteur, a Sanofi Company (177)  ·  Assistance Publique - Hôpitaux de Paris (175)  ·  Pfizer (155)  ·  Assiut University (123)  ·  Sanofi (69)  ·  AstraZeneca (65)  ·  University Hospital, Strasbourg, France (64)  ·  Novartis Vaccines (63)  ·  Duke University (62)  ·  Stanford University (59)  ·  Hospices Civils de Lyon (57)  ·  University Hospital, Montpellier (57)  ·  Cairo University (55)

Countries

United States (3855)  ·  France (1223)  ·  China (869)  ·  Canada (679)  ·  United Kingdom (678)  ·  Spain (663)  ·  Italy (591)  ·  Turkey (Türkiye) (556)  ·  Germany (537)  ·  Brazil (462)  ·  Belgium (370)  ·  Egypt (358)  ·  Russia (310)  ·  Mexico (293)  ·  South Africa (270)

Top investigators

Mike Royal, MD (16)  ·  Robert Walker, MD (16)  ·  Cornelia Dekker, MD (14)

Results publications

PMID 34473343, PMID 35244208, PMID 35713300, PMID 31986264, PMID 32031570, PMID 32109013, PMID 32091533, PMID 32171076, PMID 34013969, PMID 36734509, PMID 37162745, PMID 33502773, PMID 36695483, PMID 37489818, PMID 37591523, PMID 34658014, PMID 37010196, PMID 32167524, PMID 34350582, PMID 32142651, PMID 32192578, PMID 32250385, PMID 32007143, PMID 32105632, PMID 33044747, PMID 33215698, PMID 38597249, PMID 33757717, PMID 36435633, PMID 36715243, PMID 32085846, PMID 32105637, PMID 32205204, PMID 32738928, PMID 33301246, PMID 33306989, PMID 33395094, PMID 35695334, PMID 39903535, PMID 15616839, PMID 21435708, PMID 27158989, PMID 27344959, PMID 28963118, PMID 31978945, PMID 31995857, PMID 32020029, PMID 32112977, PMID 32125452, PMID 32219428

NIH funding

2023 (39), 2009 (29), 2015 (24), U19AI057229 (20), 2008 (19), 2016 (19), 2019 (19), 2025 (17), 2014 (16), 2018 (15), 2017 (10), U24TR001608 (8), R01AI135029 (7), P30AG034532 (6), 2005 (5)